Matthew R. Plooster - May 18, 2022 Form 4 Insider Report for KEMPHARM, INC (ZVRA)

Role
Director
Signature
/s/ Timothy J. Sangiovanni, Attorney-in-Fact for Matthew R. Plooster
Stock symbol
ZVRA
Transactions as of
May 18, 2022
Transactions value $
$24,780
Form type
4
Date filed
5/18/2022, 07:01 PM
Previous filing
Dec 1, 2021
Next filing
Jun 30, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZVRA Common Stock Purchase $3.43K +695 +27.8% $4.94 3.2K May 18, 2022 Direct F1
transaction ZVRA Common Stock Purchase $4.53K +915 +28.64% $4.95 4.11K May 18, 2022 Direct F1
transaction ZVRA Common Stock Purchase $15.1K +3.05K +74.23% $4.96 7.16K May 18, 2022 Direct F1
transaction ZVRA Common Stock Purchase $1.68K +339 +4.73% $4.97 7.5K May 18, 2022 Direct F1
holding ZVRA Common Stock 69 May 18, 2022 By TD Ameritrade Clearing Inc. Custodian FBO Matthew Ryan Plooster Roth IRA, as trustee
holding ZVRA Common Stock 1.53K May 18, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Held jointly with spouse.